Central Pacific Bank - Trust Division

Bank

Position in LLY — ELI LILLY & Co

CIK 2020066 HONOLULU, HI

Position in LLY

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$8,662,284

-$32,301 QoQ

Shares Held

7,222

-23.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

1.40%

of 13F equity value

Holder Rank

#1,345

of 4,605 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 8% Shared 0% None 92%

Healthcare · as of Jun 30, 2026

Central Pacific Bank - Trust Division holds $21,867,179 across 13 Drug Manufacturers - General names. LLY ranks #1 (39.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	7,222	$8,662,284
2	JNJ	Johnson & Johnson	16,537	$4,199,901
3	MRK	Merck & Co., Inc.	16,924	$2,174,733
4	ABBV	AbbVie Inc.	5,766	$1,450,956
5	GILD	Gilead Sciences, Inc.	9,589	$1,211,474
6	AZN	Astrazeneca PLC	5,179	$982,041
7	GSK	GSK plc	13,813	$724,077
8	BMY	Bristol Myers Squibb Co	12,054	$694,551

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,662,284	7,222	-23.6%	Shares	Defined	2026-07-07
2026-03-31	$8,694,585	9,453	+7.8%	Shares	Defined	2026-04-08
2025-12-31	$9,428,168	8,773	-2.4%	Shares	Defined	2026-01-07
2025-09-30	$6,859,370	8,990	+25.8%	Shares	Defined	2025-10-02
2025-06-30	$5,571,300	7,147	-4.5%	Shares	Defined	2025-07-02
2025-03-31	$6,182,762	7,486	+15.9%	Shares	Defined	2025-04-03
2024-12-31	$4,986,348	6,459	-38.9%	Shares	Defined	2025-01-03
2024-09-30	$9,359,070	10,564	-6.8%	Shares	Defined	2024-10-02
2024-06-30	$10,267,009	11,340	-6.2%	Shares	Defined	2024-07-30
2024-03-31	$9,404,758	12,089	—	Shares	Defined	2024-05-02
No filing history on record for this holder in this stock.